CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial
Wonyoung Choi, Jong Gwang Kim, Seung-Hoon Beom, Jun-Eul Hwang, Hyun-Jung Shim, Sang-Hee Cho, Min-Ho Shin, Sin-Ho Jung, Ik-Joo Chung, Joon Young Song, Woo Kyun Bae
Cancer Research and Treatment. 2020;52(1):246-253.   Published online 2019 July 9    DOI: https://doi.org/10.4143/crt.2019.189

Excel Download

Immunogenicity and optimal timing of 13-valent pneumococcal conjugate vaccination during adjuvant chemotherapy in gastric and colorectal cancer: A randomized controlled trial
Annals of Oncology. 2019;30:v741   Crossref logo
Link1 Link2 Link3

Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial
Cancer Research and Treatment. 2020;52(1):246-253   Crossref logo
Link1 Link2 Link3

A phase II study to assess the immunogenicity and optimal timing of 13-valent pneumococcal conjugated vaccination during adjuvant chemotherapy
Annals of Oncology. 2018;29:ix133   Crossref logo
Link1 Link2 Link3

A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients
Vaccine. 2021;39(17):2351-2359   Crossref logo
Link1 Link2

Response to Eriksson et al A randomized, controlled trial comparing the immunogenicity and safety of a 23‐valent pneumococcal polysaccharide vaccination to a repeated dose 13‐valent pneumococcal conjugate vaccination in kidney transplant recipients
Transplant Infectious Disease. 2020;23(2):   Crossref logo
Link1 Link2 Link3

A randomized, controlled trial comparing the immunogenecity and safety of a 23‐valent pneumococcal polysaccharide vaccination to a repeated dose 13‐valent pneumococcal conjugate vaccination in kidney transplant recipients
Transplant Infectious Disease. 2020;22(4):   Crossref logo
Link1 Link2 Link3 Link4

PIN43 COST-EFFECTIVENESS OF 13-VALENT AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION RELATIVE TO 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN CANADA
Value in Health. 2009;12(7):A425   Crossref logo
Link1 Link2

Immunogenicity and Immune Memory after a Pneumococcal Polysaccharide Vaccine Booster in a High-Risk Population Primed with 10-Valent or 13-Valent Pneumococcal Conjugate Vaccine: A Randomized Controlled Trial in Papua New Guinean Children
Vaccines. 2019;7(1):17   Crossref logo
Link1

Lessons learned from recent randomized controlled trials comparing the immunogenicity of different infant vaccination schedules of pneumococcal conjugate vaccine
F1000Research. 2020;9:631   Crossref logo
Link1 Link2 Link3

Effect of Reduced-Dose Schedules With 7-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Carriage in Children: A Randomized Controlled Trial
Yearbook of Pediatrics. 2011;2011:245-247   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.